News | Breast Imaging | July 12, 2022

The Strathroy Middlesex General Hospital (SMGH) has adopted Molli — a precise, easy-to-use new technology for breast cancer localization. 

medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform

July 12, 2022 — The Strathroy Middlesex General Hospital (SMGH) has adopted Molli — a precise, easy-to-use new technology for breast cancer localization. Recently, an SMGH team participated in its first breast-conserving surgical procedure using Molli. SMGH is the first hospital in the southwest Ontario region to use this technology. 

Molli Surgical’s Health Canada-approved and FDA-cleared Molli features the Molli Marker — the smallest localization marker on the market — and is designed to give a better patient experience over traditional wire localization. The Molli Wand detects the marker and visualizes its location on a tablet, helping surgeons locate lesions more efficiently with improved accuracy. Molli is also a great benefit for patients as it allows for more convenient scheduling of marker placement. 

“Molli is an innovative and revolutionary way of localizing breast masses that cannot be felt. It allows for a less painful and more effective way of finding the breast disease that needs to be removed, during surgery,” says Dr. Vipan Jain, MHA General Surgeon. “The marker can be inserted weeks before the surgical date, allowing for easier scheduling for patients and no loss of signal during surgery, making it a better option than the radioactive seed guide. Once placed, the chances of it moving and/or dislodging are virtually nonexistent, making it a better option than the conventional wire guide. We're seeing these benefits, and with the ease of use in the operating room, I believe Molli is a better option for patients.” 

“Congratulations to the team at SMGH and Molli Surgical for bringing this innovative, precision technology to our community — and for the difference it will make for Strathroy patients and for their families,” said Joanne Vanderheyden, Mayor of Strathroy-Caradoc

“We’re very pleased to do our part to help improve the patient experience with the use of Molli at Strathroy Middlesex General Hospital,” said Fazila Seker, President and CEO of Molli Surgical. “We believe that by improving the way we care for people who are experiencing breast surgery — together with creating more efficiency in radiology and surgery departments — creates a better overall experience for both physicians and their patients, and ultimately strengthens hospitals and the communities they serve.” 

For more information: http://mollisurgical.com/ 


Related Content

News | Innovative Hospitals

July 27, 2026 — Vanderbilt Health and Siemens Healthineers have entered into a multi-year, $87 million Value ...

Time July 28, 2026
arrow
News | ASTRO

July 22, 2026 — The American Society for Radiation Oncology (ASTRO) has announced the 39 members who will receive the ...

Time July 23, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Radiation Therapy

June 3, 2026 — Alpha Tau Medical Ltd. and Tolmar International Ltd. have announced a strategic collaboration agreement ...

Time June 04, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News | ASTRO

May 18, 2026 — The American Society for Radiation Oncology (ASTRO) and the European Society for Radiotherapy and ...

Time May 19, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Radiation Therapy

April 30, 2026 — The Siemens Healthineers business area, Varian, has been awarded up to $60 million over five years by ...

Time April 30, 2026
arrow
Subscribe Now